SAN DIEGO, Aug. 13, 2024 /PRNewswire/ — Inhibrx Biosciences, Inc. (Nasdaq: INBX) (“Inhibrx Biosciences” or the “Company”), a biopharmaceutical company…
Continuous Adoption of Technological Advancements and Increasing Consumer Preference for Personalized Skincare Anticipated to Create Greater Strides for Microdermabrasion Devices…